Identification of microvascular and morphological alterations in eyes with central retinal non-perfusion.
Aged
Cross-Sectional Studies
Diabetic Retinopathy
/ complications
Epiretinal Membrane
/ complications
Female
Fluorescein Angiography
Humans
Male
Microaneurysm
/ complications
Middle Aged
Retinal Vein Occlusion
/ complications
Retinal Vessels
/ diagnostic imaging
Tomography, Optical Coherence
Visual Acuity
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
06
2020
accepted:
20
10
2020
entrez:
10
11
2020
pubmed:
11
11
2020
medline:
30
12
2020
Statut:
epublish
Résumé
To evaluate the characteristics and morphological alterations in central retinal ischemia caused by diabetic retinopathy (DR) or retinal vein occlusion (RVO) as seen in optical coherence tomography angiography (OCTA) and their relationship to visual acuity. Swept-source optical coherence tomography (SSOCT) and OCTA (Topcon, Triton) data of patients with central involving retinal ischemia were analyzed in this cross-sectional study. The following parameters were evaluated: vessel parameters, foveal avascular zone (FAZ), intraretinal cysts (IRC), microaneurysms (MA), vascular collaterals in the superficial (SCP) and deep plexuses (DCP), hyperreflective foci (HRF), epiretinal membrane (ERM), external limiting membrane (ELM) and ellipsoid zone (EZ) disruption, as well as the disorganization of retinal inner layers (DRIL). Best-corrected visual acuity (BCVA), age, gender, disease duration and ocular history were also recorded. 44 eyes of 44 patients (22 with RVO, 22 with DR) were analyzed. The mean age was 60.55 ± 11.38 years and mean BCVA 0.86 ± 0.36 (Snellen, 6m). No significant difference was found between DR subgroups (non proliferative vs. proliferative). Between RVO subgroups (CRVO vs. BRVO) a significant difference was found in term of collateral vessel of the DCP (p = 0.014). A pooled DR and RVO group were created and compared. Significantly more MAs (p = 0.007) and ERM (p = 0.007) were found in the DR group. Statistically significant negative correlation was demonstrated between FAZ and BCVA (p = 0.45) when analyzing all patients with retinal ischemia. This study has shown that the best predictor of visual outcome in center involved ischemic diseases is the size of FAZ. Besides the presence of MAs and ERM, all other OCT and OCTA parameters were present in a similar extent in DR and RVO group despite the completely different disease origins. Our results suggest that as soon as retinal ischemia in the macular region is present, it has a similar appearance and visual outcome independently of the underlying disease.
Identifiants
pubmed: 33170872
doi: 10.1371/journal.pone.0241753
pii: PONE-D-20-18797
pmc: PMC7654769
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0241753Déclaration de conflit d'intérêts
The authors have declared that no competing interest exist in relation to this work.
Références
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4940-4947
pubmed: 27654421
Ophthalmology. 2016 Nov;123(11):2352-2367
pubmed: 27523615
Br J Ophthalmol. 2019 Oct;103(10):1373-1379
pubmed: 30467130
J Ophthalmol. 2019 Oct 13;2019:7589841
pubmed: 31737359
Int J Retina Vitreous. 2019 Sep 3;5:24
pubmed: 31508244
Ophthalmology. 2009 May;116(5):914-20
pubmed: 19410950
Int Ophthalmol. 2019 Oct;39(10):2361-2371
pubmed: 31119505
Arch Ophthalmol. 1975 Dec;93(12):1300-10
pubmed: 1200895
Retina. 2015 Nov;35(11):2377-83
pubmed: 26457396
PLoS One. 2011;6(11):e27385
pubmed: 22110636
Acta Ophthalmol. 2015 Dec;93(8):719-25
pubmed: 26109209
Clin Ophthalmol. 2013;7:173-8
pubmed: 23355773
Ophthalmology. 1991 May;98(5 Suppl):786-806
pubmed: 2062513
Sci Rep. 2016 Jun 28;6:29064
pubmed: 27350562
Brain Res. 2000 Mar 17;859(1):96-103
pubmed: 10720618
Retina. 2017 Sep;37(9):1700-1709
pubmed: 27828907
Retina. 2018 Aug;38(8):1571-1580
pubmed: 28671896
PLoS One. 2019 Jul 24;14(7):e0215790
pubmed: 31339897
Dev Ophthalmol. 2016;56:13-7
pubmed: 27023108
Ophthalmologica. 2013;229(1):32-7
pubmed: 23006969
Prog Retin Eye Res. 2004 Jan;23(1):91-147
pubmed: 14766318
Int J Retina Vitreous. 2019 Dec 10;5:41
pubmed: 31867124
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3907-13
pubmed: 27472076
Invest Ophthalmol Vis Sci. 2012 Dec 07;53(13):8042-8
pubmed: 23111607
Diabetes. 1961 Nov-Dec;10:452-4
pubmed: 13905439
Graefes Arch Clin Exp Ophthalmol. 2020 Jul 16;:
pubmed: 32676792
Prog Retin Eye Res. 2020 Jul;77:100828
pubmed: 31911236
Int J Ophthalmol. 2017 Apr 18;10(4):605-612
pubmed: 28503435
Ophthalmology. 1997 Jun;104(6):1033-40
pubmed: 9186446
JAMA Ophthalmol. 2014 Nov;132(11):1309-16
pubmed: 25058813
Ophthalmol Retina. 2018 Nov;2(11):1125-1132
pubmed: 30511035
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5633-5640
pubmed: 30481280